Renal ablation articles

  1. Stouvenot, M, Koch, S, Frontzcak, A, D'Engremont, C, Boinette, A, Doussot, A et al.. Effectiveness and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic metastases of renal cell carcinoma. Endosc Int Open. 2025;13 :a25667350. doi: 10.1055/a-2566-7350. PubMed PMID:40376026 PubMed Central PMC12080524.
  2. Smits, MLJ, Wijnen, N, Bruijnen, RCG, Brinkman, WM, Willemse, PM, Ramdhani, K et al.. Renal Arteriography and C-arm CT-Guided Ablation (RenACAGA) for Thermal Ablation of Challenging Renal Tumors. Cardiovasc Intervent Radiol. 2025; :. doi: 10.1007/s00270-025-04039-1. PubMed PMID:40295401 .
  3. Kim, J, Uy, M, Cheng, A, Syed, L, Almuaiqel, M, Matsumoto, E et al.. Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up. J Endourol. 2025; :. doi: 10.1089/end.2024.0849. PubMed PMID:40274368 .
  4. Koike, Y, Motohashi, K, Kuwabara, N, Miyauchi, T, Okada, M. Radiofrequency ablation of renal tumour in the supine position using a dorsal-space mat. BJR Case Rep. 2025;11 (2):uaaf025. doi: 10.1093/bjrcr/uaaf025. PubMed PMID:40270552 PubMed Central PMC12017616.
  5. Borghi, C, Bragagni, A. In these cases, I treat hypertension with renal ablation. Eur Heart J Suppl. 2025;27 (Suppl 3):iii32-iii35. doi: 10.1093/eurheartjsupp/suaf012. PubMed PMID:40248286 PubMed Central PMC12001763.
  6. Fisher, G, Kaufman, H, Wilcox, A, Torralba, E, Boldman, E, Boyer, B et al.. Percutaneous Microwave Ablation of Small (<4 cm) Renal Masses Performed under Moderate Sedation. J Vasc Interv Radiol. 2025; :. doi: 10.1016/j.jvir.2025.03.024. PubMed PMID:40209844 .
  7. Gonçalves, OR, de Melo Neto, AP, Machado Pereira, MAO, Ohannesian, VA, Fernandes, MAN, Dantas, CR et al.. Renal denervation plus cardiac ablation vs. cardiac ablation alone for patients with atrial fibrillation and uncontrolled arterial hypertension : A systematic review and updated meta-analysis of randomized controlled trials. Herz. 2025; :. doi: 10.1007/s00059-025-05302-4. PubMed PMID:40204910 .
  8. Pickersgill, NA. Editorial Comment on "A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (Radster)". Urology. 2025; :. doi: 10.1016/j.urology.2025.04.003. PubMed PMID:40204106 .
  9. Torres, TP, Liakopoulos, I, Balomenos, V, Grigoriadis, S, Papakonstantinou, O, Kelekis, N et al.. Adjunctive techniques for renal cell carcinoma ablation: an update. Front Radiol. 2025;5 :1559411. doi: 10.3389/fradi.2025.1559411. PubMed PMID:40165795 PubMed Central PMC11955682.
  10. Askarpour, M, Aminsharifi, A. Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation. Cancers (Basel). 2025;17 (6):. doi: 10.3390/cancers17060974. PubMed PMID:40149308 PubMed Central PMC11940802.
  11. Chan, VW, Ng, HH, Abdulrauf, K, Zaman, H, Ahmed, A, Zhong, J et al.. Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments. Medicina (Kaunas). 2025;61 (3):. doi: 10.3390/medicina61030438. PubMed PMID:40142250 PubMed Central PMC11943572.
  12. Baer, BR, Matheny, MV, Mercedes, RH, Raman, JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Curr Oncol. 2025;32 (3):. doi: 10.3390/curroncol32030125. PubMed PMID:40136329 PubMed Central PMC11940996.
  13. Travesso, DJ, de Melo, RAB, Almeida, MFA, Motta-Leal-Filho, JM, Moura, EBS, Machado, F et al.. T1b Renal Masses Radiofrequency Ablation: Feasibility, Safety, and Efficacy in Midterm Follow-Up. Int J Urol. 2025; :. doi: 10.1111/iju.70042. PubMed PMID:40062605 .
  14. Cassim, R, Bansal, R, Millan, B, Mironov, O, Ahir, P, Tajzler, C et al.. A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER). Urology. 2025; :. doi: 10.1016/j.urology.2025.02.053. PubMed PMID:40058468 .
  15. Schaarschmidt, BM, Zensen, S, Kesch, C, Dertnig, T, Opitz, M, Drews, M et al.. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy. Eur Radiol. 2025;35 (3):1723-1731. doi: 10.1007/s00330-024-11343-w. PubMed PMID:40016555 PubMed Central PMC11868359.
  16. Carbonara, U, Ditonno, F, Beksac, AT, Derweesh, I, Cerrato, C, Celia, A et al.. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025;51 (2):. doi: 10.1590/S1677-5538.IBJU.2024.0565. PubMed PMID:39913094 PubMed Central PMC11884627.
  17. Wells, SA, Shapiro, D, Borza, T, Allen, G, Hinshaw, JL, Ziemlewicz, TJ et al.. Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04794-8. PubMed PMID:39912925 .
  18. Li, G, Chen, Y, Zhang, X. Percutaneous laser ablation vs. radical nephroureterectomy: a comparative study on renal pelvic tumors. Int Urol Nephrol. 2025; :. doi: 10.1007/s11255-025-04395-4. PubMed PMID:39904823 .
  19. Elhakim, TS, Lodhi, T, Fidelis, W, Brea, A, Mort, A, Mohagheghtabar, M et al.. Management of renal cell carcinoma with ablation in comparison to nephrectomy: A 5-year analysis of inpatient procedural data to evaluate utilization disparities in the United States. Clin Imaging. 2025;119 :110412. doi: 10.1016/j.clinimag.2025.110412. PubMed PMID:39862649 .
  20. Ochsner, A, Malshy, K, Golijanin, B, Mega, A, Collins, S, Maxwell, A et al.. Adrenal Metastasis Ablation in Oligometastatic Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2025;23 (2):102295. doi: 10.1016/j.clgc.2024.102295. PubMed PMID:39854956 .
Search PubMed